The drug price deal between Pfizer and the Trump administration was built on down-to-the-wire team negotiations, building on a relationship between CEO Albert Bourla and President Trump
We use cookies to provide you with the best browsing experience. By continuing to use our site, you agree to our use of cookies for analytics, personalization, and functional purposes. You can adjust your preferences or learn more in our Cookie Policy.